Bioleaders Corporation announced a private placement to issue Series 10 Bearer-Bearing Interest-Bearing, Unsecured Private Placement Convertible Bonds for the gross proceeds of KRW 2,000,000,000 on December 29, 2023. The bonds will be 100% convertible into 946,969 shares at a conversion price of KRW 2,112 per share in a conversion period starting from January 2, 2025 and ending on December 2, 2026. The maturity date of the bonds is January 2, 2027.

The transaction is expected to close on January 2, 2024. The transaction has been approved by the board of directors of the company.